Aino Fianu Jonasson

About me
Publications
Public outreach and news

About me

Aino Fianu Jonasson is specialist in urogynecology and is responsible for the Womens health department at Karolinska University Hospital Huddinge. Was registered physician, National Board of Health on 21 Feb 1986 and became specialist in Obstetrics and Gynecology on the 30 Sep 1990. Has published several publications.

Research

Urinary incontinence Osteoporos Studies of endometrios in women who are infertile Ainos research group

Teaching

Has been director of studies and responsible of teaching medical students from 1996 until 2009. She has also been training junior doctors and undertaking clinical research. She has published several publications

Articles

Article: ADVANCES IN UROLOGY. 2021;2021:8822186-9

A Vaginal Inlay for Reduction of Stress Urinary Incontinence: Outcome of a Randomized Clinical Trial and Four User Acceptance Studies.

Jonasson AF; Bryder K; Sthengel E
Article: ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA. 2021;100(2):339-346

The cytokine profile of menstrual blood.

Crona Guterstam Y; Strunz B; Ivarsson MA; Zimmer C; Melin A-S; Jonasson AF; Björkström NK; Gidlöf SB
Article: MEDICAL DEVICES: EVIDENCE AND RESEARCH. 2021;14:193-200

An Open, Uncontrolled Pilot Study on 12-Week Use of VagiVital for Treatment of Vulvovaginal Atrophy in Breast Cancer Patients Undergoing Adjuvant Aromatase-Inhibitor Therapy.

Jonasson AF; Åstrom M
Article: MEDICAL DEVICES: EVIDENCE AND RESEARCH. 2020;13:339-347

Safety and Efficacy of an Oxytocin Gel and an Equivalent Gel but Without Hormonal Ingredients (Vagivital® Gel) in Postmenopausal Women with Symptoms of Vulvovaginal Atrophy: A Randomized, Double-Blind Controlled Study.

Fianu Jonasson A; Bixo M; Sundström Poromaa I; Åstrom M
Article: PRENATAL DIAGNOSIS. 2019;39(11):1011-1015

Clinical validation of a novel automated cell-free DNA screening assay for trisomies 21, 13, and 18 in maternal plasma.

Ericsson O; Ahola T; Dahl F; Karlsson F; Persson F; Karlberg O; Roos F; Alftrén I; Andersson B; Barkenäs E; Boghos A; Brandner B; Dahlberg J; Forsgren P-O; Francois N; Gousseva A; Hakamali F; Janfalk-Carlsson Å; Johansson H; Lundgren J; Mohsenchian A; Olausson L; Olofsson S; Qureshi A; Skarpås B; Svahn P; Sävneby A; Åström E; Sahlberg A; Fianu-Jonasson A; Gautier J; Costa J-M; Jacobsson B; Nicolaides K
Article: SCIENTIFIC REPORTS. 2018;8(1):4549

Imaging single DNA molecules for high precision NIPT.

Dahl F; Ericsson O; Karlberg O; Karlsson F; Howell M; Persson F; Roos F; Stenberg J; Ahola T; Alftrén I; Andersson B; Barkenäs E; Brandner B; Dahlberg J; Elfman S; Eriksson M; Forsgren P-O; Francois N; Gousseva A; Hakamali F; Janfalk-Carlsson Å; Johansson H; Lundgren J; Mohsenchian A; Olausson L; Olofsson S; Qureshi A; Skarpås B; Sävneby A; Åström E; Öhman O; Westgren M; Kopp-Kallner H; Fianu-Jonasson A; Syngelaki A; Nicolaides K
Article: JOURNAL OF CLINICAL PHARMACOLOGY. 2017;57(12):1573-1581

Population Pharmacokinetic Analysis of Vaginally and Intravenously Administered Oxytocin in Postmenopausal Women.

Nielsen EI; Al-Saqi SH; Jonasson AF; Uvnäs-Moberg K
Article: EUROPEAN JOURNAL OF HEALTH ECONOMICS. 2017;18(6):761-771

Annual direct and indirect costs attributable to nocturia in Germany, Sweden, and the UK.

Weidlich D; Andersson FL; Oelke M; Drake MJ; Jonasson AF; Guest JF
Article: PSYCHONEUROENDOCRINOLOGY. 2017;80:46-55

Treatment of premenstrual dysphoric disorder with the GABAA receptor modulating steroid antagonist Sepranolone (UC1010)-A randomized controlled trial.

Bixo M; Ekberg K; Poromaa IS; Hirschberg AL; Jonasson AF; Andréen L; Timby E; Wulff M; Ehrenborg A; Bäckström T
Article: JOURNAL OF UROLOGY. 2016;196(3):809-818

Mirabegron as Add-On Treatment to Solifenacin in Patients with Incontinent Overactive Bladder and an Inadequate Response to Solifenacin Monotherapy: Responder Analyses and Patient-Reported Outcomes from the BESIDE Study [corrected].

MacDiarmid S; Al-Shukri S; Barkin J; Fianu-Jonasson A; Grise P; Herschorn S; Saleem T; Huang M; Siddiqui E; Stölzel M; Hemsted C; Nazir J; Hakimi Z; Drake MJ; BESIDE Investigators
Article: POST REPRODUCTIVE HEALTH. 2016;22(1):25-33

Oxytocin improves cytological and histological profiles of vaginal atrophy in postmenopausal women.

Al-Saqi SH; Jonasson AF; Naessén T; Uvnäs-Moberg K
Article: POST REPRODUCTIVE HEALTH. 2015;21(3):88-97

Intravaginally applied oxytocin improves post-menopausal vaginal atrophy.

Al-Saqi SH; Uvnäs-Moberg K; Jonasson AF
Article: CELL AND TISSUE BANKING. 2015;16(2):181-193

Defined serum- and xeno-free cryopreservation of mesenchymal stem cells.

Al-Saqi SH; Saliem M; Quezada HC; Ekblad Å; Jonasson AF; Hovatta O; Götherström C
Article: SENSORS. 2014;14(11):20589-20601

Automatic classification of the sub-techniques (gears) used in cross-country ski skating employing a mobile phone.

Stöggl T; Holst A; Jonasson A; Andersson E; Wunsch T; Norström C; Holmberg H-C
Article: CYTOTHERAPY. 2014;16(7):915-926

Defined serum-free media for in vitro expansion of adipose-derived mesenchymal stem cells.

Al-Saqi SH; Saliem M; Asikainen S; Quezada HC; Ekblad A; Hovatta O; Le Blanc K; Jonasson AF; Götherström C
Article: NEUROUROLOGY AND URODYNAMICS. 2014;33(1):90-94

Clinical value of a patient-reported goal-attainment measure: the global development of self-assessment goal achievement (SAGA) questionnaire for patients with lower urinary tract symptoms.

Khullar V; Espuna-Pons M; Marschall-Kehrel D; Fianu-Jonasson A; Kelleher CJ; Brubaker L; Beach J; Piault E; Trocio J
Article: INTERNATIONAL UROGYNECOLOGY JOURNAL. 2013;24(9):1529-1536

European content validation of the Self-Assessment Goal Achievement (SAGA) questionnaire in patients with overactive bladder.

Khullar V; Marschall-Kehrel D; Espuna-Pons M; Kelleher CJ; Tully SE; Piault EC; Brubaker L; Fianu-Jonasson A; Weinstein D; Bergqvist A; Kvasz M
Article: MENOPAUSE INTERNATIONAL. 2011;17(4):120-125

Topical oxytocin reverses vaginal atrophy in postmenopausal women: a double-blind randomized pilot study.

Jonasson AF; Edwall L; Uvnäs-Moberg K
Article: PLOS ONE. 2010;5(12):e15580

Vitamin D induction of the human antimicrobial Peptide cathelicidin in the urinary bladder.

Hertting O; Holm Å; Lüthje P; Brauner H; Dyrdak R; Jonasson AF; Wiklund P; Chromek M; Brauner A
Article: MATURITAS. 2008;60(2):138-147

Efficacy and safety of duloxetine in elderly women with stress urinary incontinence or stress-predominant mixed urinary incontinence.

Schagen van Leeuwen JH; Lange RR; Jonasson AF; Chen WJ; Viktrup L
Article: MOLECULAR HUMAN REPRODUCTION. 2008;14(3):193-197

Markers of collagen synthesis and degradation in urogenital tissue and serum from women with and without uterovaginal prolapse.

Edwall L; Carlström K; Fianu Jonasson A
Article: EUROPEAN UROLOGY. 2007;52(4):1195-1203

Treatment outcomes in the STAR study: a subanalysis of solifenacin 5 mg and tolterodine ER 4 mg.

Chapple CR; Fianu-Jonsson A; Indig M; Khullar V; Rosa J; Scarpa RM; Mistry A; Wright DM; Bolodeoku J; STAR study group
Article: NEUROUROLOGY AND URODYNAMICS. 2007;26(3):410-415

Endocrine status and markers of collagen synthesis and degradation in serum and urogenital tissue from women with and without stress urinary incontinence.

Edwall L; Carlström K; Jonasson AF
Article: BMC WOMENS HEALTH. 2006;6:16

The clinical diagnosis of pelvic inflammatory disease--reuse of electronic medical record data from 189 patients visiting a Swedish university hospital emergency department.

Eggert J; Sundquist K; van Vuuren C; Fianu-Jonasson A
Article: INTERNATIONAL JOURNAL OF CLINICAL PRACTICE. 2006;60(10):1181-1186

Magnetic resonance imaging to evaluate NASHA/Dx gel (Zuidex) for stress urinary incontinence.

Fianu-Jonasson A; Edwall L; Wiberg MK
Article: MATURITAS. 2006;53(1):89-96

Conjugated estrogen/progestagen versus tibolone hormone replacement therapy in postmenopausal women: Effects on carbohydrate metabolism and serum sex hormone-binding globulin.

Odmark I-S; Carlström K; Jonsson B; Jonasson AF
Article: CLINICAL DRUG INVESTIGATION. 2006;26(10):583-591

Treatment of stress urinary incontinence with non-animal stabilised hyaluronic acid/dextranomer (NASHA/Dx) gel : An analysis of utility and cost.

Kobelt G; Fianu-Jonasson A
Article: FERTILITY AND STERILITY. 2005;84(3):692-700

Microvascular density, vascular endothelial growth factor A, and its receptors in endometrial blood vessels in patients with menorrhagia.

Mints M; Blomgren B; Falconer C; Fianu-Jonasson A; Palmblad J
Article: EUROPEAN UROLOGY. 2005;48(3):488-494

An open, multicentre study of NASHA/Dx Gel (Zuidex) for the treatment of stress urinary incontinence.

Chapple CR; Haab F; Cervigni M; Dannecker C; Fianu-Jonasson A; Sultan AH
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2005;49(1):170-175

Ecological effects of perorally administered pivmecillinam on the normal vaginal microflora.

Sullivan A; Fianu-Jonasson A; Landgren B-M; Nord CE
Article: NEUROUROLOGY AND URODYNAMICS. 2005;24(4):319-324

Markers of collagen synthesis and degradation in urogenital tissue from women with and without stress urinary incontinence.

Edwall L; Carlström K; Jonasson AF
Article: BJU INTERNATIONAL. 2004;94(7):1040-1043

Treatment of stress urinary incontinence using a copolymer system: impact on quality of life.

van Kerrebroeck P; ter Meulen F; Larsson G; Farrelly E; Edwall L; Fianu-Jonasson A
Article: UROLOGY. 2004;64(2):276-281

Efficacy and safety of a novel system (NASHA/Dx copolymer using the Implacer device) for treatment of stress urinary incontinence.

van Kerrebroeck P; ter Meulen F; Larsson G; Farrelly E; Edwall L; Fianu-Jonasson A
Article: ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA. 2003;82(11):1060

Stress urinary incontinence: feasibility of surgery after urethral injection.

Fianu-Jonasson A; Edwall L
Article: UROLOGICAL RESEARCH. 2003;30(6):356-362

Treatment of stress urinary incontinence: recent developments in the role of urethral injection.

van Kerrebroeck P; ter Meulen F; Farrelly E; Larsson G; Edwall L; Fianu-Jonasson A
Article: NEUROUROLOGY AND URODYNAMICS. 2001;20(5):591-599

Effectiveness of two conservative modes of physical therapy in women with urinary stress incontinence.

Arvonen T; Fianu-Jonasson A; Tyni-Lenné R
Article: BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY. 1999;106(2):95-101

Changed pattern in the use of episiotomy in Sweden.

Röckner G; Fianu-Jonasson A
Article: HUMAN FERTILITY. 1999;2(2):127-132

Difference in mRNA expression and occurrence of plasminogen activator inhibitors in intrauterine decidua of normal and ectopic human pregnancies.

Jonasson A; Larsson B; Lecander I; Åstedt B; Larsson J; Hansson SR; Lindoff C
Show more

All other publications

Corrigendum: CELL AND TISSUE BANKING. 2019;20(2):329-330

Correction to: Defined serum- and xeno-free cryopreservation of mesenchymal stem cells.

Al-Saqi SH; Saliem M; Quezada HC; Ekblad Å; Jonasson AF; Hovatta O; Götherström C
Editorial comment: UROLOGY. 2017;104:1-4

Adding Mirabegron to Solifenacin to Treat Overactive Bladder Has Little Impact on Postvoid Residual Volume or Urinary Retention Risk.

Drake MJ; MacDiarmid S; Al-Shukri S; Barkin J; Fianu-Jonasson A; Herschorn S; Huang M; Stoelzel M; Siddiqui E
Published paper: FERTILITY AND STERILITY. 1998;70(5):821-826

Fibrinolytic factors in endometriotic tissue, endometrium, peritoneal fluid, and plasma from women with endometriosis and in endometrium and peritoneal fluid from healthy women.

Bruse C; Bergqvist A; Carlström K; Fianu-Jonasson A; Lecander I; Astedt B

About me

Research

Teaching

Articles

All other publications

News from KI

Events from KI